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Human Immunodeficiency Viruses (HIV-1 and HIV-2)
rely upon host-encoded proteins to facilitate their
replication. Here, we combined genome-wide siRNA
analyses with interrogation of human interactome
databases to assemble a host-pathogen biochemi-
cal network containing 213 confirmed host cellular
factors and 11 HIV-1-encoded proteins. Protein
complexes that regulate ubiquitin conjugation, pro-
teolysis, DNA-damage response, and RNA splicing
were identified as important modulators of early-
stage HIV-1 infection. Additionally, over 40 new fac-
tors were shown to specifically influence the initiation
and/or kinetics of HIV-1 DNA synthesis, including
cytoskeletal regulatory proteins, modulators of post-
translational modification, and nucleic acid-binding
proteins. Finally, 15 proteins with diverse functional
roles, including nuclear transport, prostaglandin
synthesis, ubiquitination, and transcription, were
found to influence nuclear import or viral DNA inte-
gration. Taken together, the multiscale approach de-
scribed here has uncovered multiprotein virus-host
interactions that likely act in concert to facilitate the
early steps of HIV-1 infection.
INTRODUCTION
Over the course of the last several decades, a number of host cell
proteins that influence the early steps of retroviral replicationhave been defined (Goff, 2007). However, it is likely that many
other cellular factors and processes are exploited by the virus
during these stages, which involves uncoating steps that give
rise to an active reverse transcription complex (RTC), movement
of the viral preintegration complex (PIC) to the cell nucleus, and
then integration of the linear viral DNA into a host cell chromo-
some to generate the provirus (Nisole and Saib, 2004). Recently,
a genome-wide siRNA analysis revealed over 250 host cellular
factors that influence HIV-1 infection (Brass et al., 2008). Nota-
bly, only a small fraction of these factors was proposed to influ-
ence the early stages of HIV-1 replication, making it likely that
additional cellular factors that regulate these steps remain to
be identified. Here, we present a genome-wide analysis of virus-
host interactions affecting the early steps of HIV-1 infection.
RESULTS
In this study, we combined several genome-wide analytical
methods to characterize the host factors required in the early
stepsofHIV infection.Weperformedgenome-wideRNAi screens
for genes required for infection by utilizing a single-cycle HIV-1
reporter virus engineered to encode luciferase and bearing the
Vesicular Stomatitis Virus Glycoprotein (VSV-G) on its surface
to facilitate efficient infection (Figure 1A). As controls, parallel
screens were performed with other viral vectors encoding
luciferase: (1) Moloney murine leukemia virus (MuLV) vector
pseudotyped with VSV-G, and (2) an adeno-associated virus
(AAV) vector (Figure S1 available online). Prior to infection, human
293T cells were transfectedwith an arrayed genome-wide siRNA
library,which targets20,000humangenes. Typically, six unique
siRNAs were used to interrogate each gene, with two siRNAs
targeting the same gene arrayed in a single well (3 wells/gene)Cell 135, 49–60, October 3, 2008 ª2008 Elsevier Inc. 49
Figure 1. Integrative Analysis of HIV-Host Interactions
(A) To monitor the early stages of HIV replication, we carried out infections by using a single cycle, VSV-G-pseudotyped, HIV-1 vector encoding luciferase
(pNL43R+E luc (VSV-G)).
(B) Human 293T cells were transfected with an arrayed genome-wide siRNA library and then challenged with HIV (VSV-G) encoding the luciferase gene. Infection
was monitored by measuring luciferase activity. Additionally, counterscreens were performed to identify those host factors affecting gammaretrovirus (MuLV) or
parvovirus (AAV) infection, as well as cellular viability (toxicity).
(C) Inhibition data for each gene were normalized, scaled, and enriched for genes that have at least two siRNAs supporting their activity (RSA analysis).
Comparative analysis of all viral screens, after filtering for toxicity, was visualized through hierarchical clustering.
(D) To facilitate the validation of biologically relevant functional and biochemical activities, we employed a multiscale approach to select candidate genes for
further study. In addition to identifying genes based on either gene (RSA) or single siRNA activity in the genome-wide assay, an ‘‘evidence score’’ was compiled
for each gene based upon a variety of other supporting criteria. Specifically, proteins, which were encompassed in statistically significant host-protein interaction
networks (Network 0, Network 1, MCODE), or had significant network connectivity with other putative host factors (local connectivity) or HIV-encoded proteins
(HIV Direct/Indirect interaction), were given additional consideration. Furthermore, genes identified through the genome-wide assay, which were members of
overrepresented functional groups (ontology/OPI), or had coincident expression with CD4/CXCR4 or CD4/CXCR5 were also given additional weight. The plot
depicts the activities and support evidence of 295 genes for which activities were subsequently confirmed by two or more siRNAs (Table S3).(Figure 1B). The toxicity associated with each pair of siRNAs was
also measured by assaying viable cell numbers (Figure 1B).
Since the primary screen was executed in an arrayed format,
we were able to employ Redundant siRNA Analysis (RSA) to
identify genes that were significantly inhibited by at least two in-
dependent siRNAs, many of which possessed reproducible, but
moderate, activities (45% or greater reduction of HIV infectivity)
(Konig et al., 2007). This analysis revealed that a significant
fraction of host proteins required by HIV-1 is also required by
MuLV (80%) (Figure 1C). These proteins included a number of50 Cell 135, 49–60, October 3, 2008 ª2008 Elsevier Inc.factors that are already known to affect retroviral replication
(Brass et al., 2008; Goff, 2007) (Table S1).
To characterize the interactions between HIV-1 and these host
cell proteins, we developed an integrative approach that consid-
ered additional lines of functional, biochemical, or transcriptional
data (collectively called ‘‘evidence score’’) for candidate gene
verification. This approach is based on the assumption that a
cellular factor is more likely to be a proximal regulator of viral
replication if its activity is supported by multiple independent
lines of evidence.
Using a yeast two-hybrid (Y2H) human protein-protein interac-
tion database (Hynet) (Mukherji et al., 2006), we identified an
extended interactome network, which contained 2458 putative
host cellular factors affecting HIV infection that form 120,211
direct or indirect interactions (Network 0; data not shown). This
network map was further refined by removing protein clusters,
which influenced infection by the AAV vector or were associated
with cellular toxicity (Network 1; p < 0.001) (Figure S2A). Addi-
tionally, we applied a graph theoretic clustering algorithm
(MCODE) to Network 1 to identify regions of locally enhanced
connectivity (Figures S2B–S2G) (Bader and Hogue, 2003).
Finally, since the Hynet Y2H data set employed in these analyses
did not contain virus-host protein-protein interactions, we inte-
grated protein interaction relationships contained in the NIAID
HIV-1, Human Protein Interaction Database (http://www.ncbi.
nlm.nih.gov/RefSeq/HIVInteractions/), as well as newly gener-
ated HIV/host Y2H interaction data in which each of the HIV-
encoded proteins was tested individually against a library of
human proteins (see Experimental Procedures). The resulting
host-pathogen interaction map between Network 0 proteins
and HIV-encoded proteins was determined to be of high statis-
tical significance (direct interactions, p = 0.005; indirect interac-
tions, p = 10103, see Supplemental Data).
In an effort to identify those genes most relevant to HIV-1
infection, the mRNA expression profiles of the identified host
genes, extracted from the GNF Expression database (http://
symatlas.gnf.org), were also correlated to those of the viral
receptor CD4 and coreceptors CXCR4 and CCR5. The majority
of host proteins in Network 0 displayed strong expression
patterns in tissues of lymphoid and neuronal origin (Figure S3).
In a subsequent analysis for each candidate host factor, we
calculated correlation coefficients with CD4/CXCR4 and CD4/
CCR5 coexpression and incorporated this value into the evi-
dence score (see Experimental Procedures). Finally, to correlate
gene functions, processes, components, or domains with gene
activities across the four assays previously described (siRNA
screens against the three viral vectors, and cytotoxicity), we em-
ployed an ontogeny-based pattern identification algorithm (OPI)
and identified over 100 enriched activity signatures across the
four genome-wide screens (Figure S4; Table S2). Since OPI
activity profiles are supported by multiple functionally related
genes and are statistically reliable (p < 0.05), they were also
considered as favorable evidence for the elucidation of physio-
logically relevant host cellular factors.
We combined these lines of evidence into a decision matrix to
prioritize those factors that are likely regulators of HIV-1 replica-
tion. Criteria included gene-based (RSA score) and siRNA-based
activity, gene expression signatures, gene ontology data (OPI),
cellular protein-protein interaction (using Network 0, Network 1,
MCODE, and local connectivity), and virus-host interaction data
(HIV Direct/Indirect) (Figures 1D and S2; Table S2; data not
shown). This enabled us to identify 800 strongly supported
genes based on evidence scores; 295 of these genes have
been confirmed to inhibit HIV (VSV-G) infection by more than
45%with at least 2 siRNAs while not significantly affecting cellu-
lar viability (Table S3). Most confirmed factors showed broad
expression in cell types relevant to HIV pathogenesis (Figure S3),
and, in addition, 75 of the confirmed factors share highly coinci-dent expression patterns with CD4/CXCR4 or CD4/CCR5
(Figures 2A and 3).
Next, we reanalyzed these confirmed factors to identify over-
represented biological annotations or protein families based on
gene ontology or Interpro (IPR) databases, respectively (p < 0.01;
Figure S5; Table S4). This analysis elucidated 176 statistically
enriched biological terms, including over 25 functional pro-
cesses or protein domains that influence HIV (VSV-G) infection
(Figure 2B). Since functional overrepresentation was one of the
criteria used to select genes for further study, many of these
classifications reflected functional categories identified in the
OPI analysis conducted across the four genome-wide screens
(Figure S4; Table S2). Among others, a collection of genes in-
volved in DNA repair and nucleoside diphosphate (NUDIX)
hydrolase activity as well as members of the Tripartite Motif
(TRIM) family of proteins were implicated as factors likely to be
important for early HIV (VSV-G) infection (Figure 2C).
To visualize the global topography of HIV-host interactions, we
reconstructed a network based upon the 295 HIV host cellular
factors confirmed in secondary assays. Using Hynet, as well as
additional protein-protein interaction databases (see Experimen-
tal Procedures), we assessed the network connectivity of these
confirmed factors and additional host and HIV-encoded proteins
(Figure3A, inset; FigureS6;TableS5).Thishost-pathogen interac-
tion network contained 213 functionally validated and 169 pre-
dicted HIV host cellular nodes, which were internally connected
via 2291 binary protein interactions, and 318 interactions to HIV-
encoded proteins (p < 3 3 106). To identify densely connected
local network neighborhoods, we executed aMolecular Complex
Detection (MCODE)analysis,which revealedseveral subnetworks
with high local network connectivity (Figure 3A). Strikingly, the
functional activities of these protein clusters reflect classifications
identified by using the GO and OPI analysis, including the ubiqui-
tin-proteasome pathway, DNA transcription and repair, and
nucleic acid binding, further underscoring their importance in
the direct regulation of early-stage HIV replication (Figures 3B–3I).
Quantitative PCR analysis of viral DNA products was per-
formed to determine the effects of siRNAs on specific steps of
early HIV-1 replication (Figure 4A, left panel). To analyze the ac-
cumulation of reverse transcription products, cells transfected
with siRNAs targeting confirmed host factors were infected
with the VSV-G-pseudotyped HIV-1 vector, and total DNA was
extracted for analysis at either 12 hr or 24 hr postinfection. A
reduction in viral DNA indicates that the targeted genes were
acting either to promote synthesis or inhibit degradation. Control
tests performed with inactivated virus or with an inhibitor of
reverse transcription (AZT) showed strong inhibition at the
expected steps of virus replication (Figure 4B, top panel).
Analysis of the siRNA activities indicates that factors affecting
reverse transcription can be segregated into at least two distinct
functional classes, those that are absolutely required for viral
DNA synthesis (AKAP13 to SPEN) and those that appear to affect
the kinetics of viral DNA synthesis (MED7 to SUMO2) (Figure 4A,
right panel; Table S6). A third set of proteins was found to affect
HIV-1 uncoating or reverse transcription (AP1G2 to TRIAD3), but,
based upon statistical criteria, could not be placed into either
functional class (Figure 4A, right panel). We hypothesize that
factors that fall within the first group influence a step that isCell 135, 49–60, October 3, 2008 ª2008 Elsevier Inc. 51
Figure 2. Characterization of Confirmed Factors Required for Infection by the VSV-G-Pseudotyped HIV-1 Vector
(A) Tissue expression of 75 confirmed host cellular factors with statistically coincident expression profiles to HIV receptor/coreceptors CD4/CXCR4 or CD4/
CXCR5 (p < 0.05, standard chi-square test, RCD4,CXCR4R 0.18, RCD4,CCR5R 0.13). Tissues and cell types are shown in the x axis, while genes are displayed
on the y axis, using a continuum of green (low expression) to red (high expression). mRNA transcriptional signatures were extracted from the Genomics Institute
of the Novartis Research Foundation expression database (http://symatlas.gnf.org).
(B) Statistically significant overrepresentation of functional classes and protein families based upon gene ontology (GO) and interpro (IPR) domainmapping of 295
confirmed host factors required for HIV infection (Table S4). P values were calculated by an accumulated hypergeometric distribution function (Zar, 1999).
(C) Relative activities of confirmed genes, each represented by two active siRNAs, across HIV, MuLV, and cytotoxicity assays (TOX) are shown from strong (blue)
to weak (yellow) (Figure S4; Table S2). Functional classes are derived from an ontogeny-based pattern identification algorithm (OPI & Knowledge Database Clus-
ters) or GO/IPR overrepresentation analysis of primary screening data. All measurements represent the mean of at least four assays, and activities not tested or
unconfirmed are depicted in gray. To identify those factors most likely to influence the intracellular steps of HIV-1 replication, a subgroup of genes was further
assayed and confirmed to inhibit infection by an HIV-1 vector pseudotyped with the 10A1 MuLV envelope protein, a viral envelope protein that directs
pH-independent viral entry at the plasma membrane. These genes are indicated with an asterisk (*) (also see Table S3).important for capsid uncoating or initiation of reverse transcrip-
tion, or else inhibit degradation of the viral DNA after synthesis.
Conversely, we predict that the siRNAs, which alter the kinetics
of reverse transcription, target cellular cofactors that facilitate,
but are not essential to, the process (Figure 4A). Additional
studieswill be required to determine if delayed viral DNA synthesis52 Cell 135, 49–60, October 3, 2008 ª2008 Elsevier Inc.in the absence of these genes produces PICs that are competent
for integration. However, we anticipate that these kinetic factors
are likely to play critical roles in maintaining viral fitness in vivo.
Additional PCR-based assays were used to identify those fac-
tors that play roles in either nuclear import of the viral PIC or viral
DNA integration. The amount of 2-LTR circular forms of viral
DNA was quantified and served as markers of blocks either to
nuclear import (reduction in 2-LTR circles) or to integration (ac-
cumulation of 2-LTR circles). In addition, viral DNA integration
was quantified by taking advantage of the amplification of HIV
DNA sequences adjacent to cellular Alu repeats (Butler et al.,
2001) (Figure 5A). For control purposes, parallel infections
were performed in the presence of an HIV-1 integrase inhibitor
(Hazuda et al., 2000).
A total of 15 genes were identified that, when targeted by cog-
nate siRNAs, significantly reduced viral DNA integration (p <
0.001) (Figure 5A; Table S7). The activities of all functional
siRNAs targeting the same genewere combined to classify these
factors into two categories based on the quantitative PCR as-
Figure 3. Network Topology of HIV-Host
Protein Interactions
(A–I) The interaction network was elucidated based
upon protein-protein binding data derived from the
Hynet yeast two-hybrid (Y2H) database (blue connec-
tors) and additional various human protein interaction
databases (green connectors). Furthermore, connec-
tions to HIV-encoded proteins (light blue) were com-
pleted by incorporation of data from the HIV-1,
Human Protein Interaction Database (NIAID) (red con-
nectors). (A, inset) The resulting network contained
2291 direct protein interactions, connecting 213 con-
firmed host cellular factors, 11 HIV proteins, and 169
additional human proteins, which interact directly
with at least two confirmed HIV host factors and one
HIV-encoded protein (Figure S6). Using permutation
testing, the density of protein interactions in this net-
work was found to be significantly enriched (p < 3 3
106). (A) To identify potential molecular complexes,
this network was analyzed for highly connected local
network modules (MCODE). (B–I) Importantly, a num-
ber of these densely connected areas formed distinct
functional subgroups, suggesting that they represent
multiprotein complexes, which directly interact with
viral factors to facilitate HIV replication. HIV-encoded
proteins were abbreviated as follows: CA, Capsid;
GAG, gag polyprotein; MA, Matrix; VPR, Vpr; NC,
Nucleocapsid; IN, Integrase; VIF, Vif; VPU, Vpu; RT,
Reverse Transcriptase; PRO, Protease; P1, p1.
says. In the first category, RNAi knockdowns
resulted in a reduction in integration and an
increase in 2-LTR circles, indicating effects
on viral DNA integration itself (ANAPC2 to
IK) (Figure 5A). In the second category, little
or no reduction in 2-LTR circles was seen, in-
dicating a block to nuclear import (TNPO3 to
NUP153) (Figure 5A). One factor, CHADL/
LOC150356, could initially not be definitely
placed, but further analysis suggests that it
is likely involved in regulating viral DNA inte-
gration (Figure S7).
Several of the identified factors were
members of the nucleocytoplasmic trans-
port machinery. Unexpectedly, inhibition of
these factors affected HIV-1 infection at
two different steps. NUP153 and RANBP2
seemed to be involved in nuclear import of the PIC (Figure 5B,
upper panel). In contrast, the nuclear import protein KPNB1 (im-
portin b-1) as well as NUP98 seemed to be required for viral in-
tegration. (Figure 5B, middle panel). These results suggest that
the karyopherin and the nucleoporin can regulate viral DNA inte-
gration at a postnuclear entry step; however, additional studies
will be helpful in determining whether they act directly on viral nu-
cleoprotein complexes or regulate a host cellular factor required
for integration.
Four out of six of the cellular factors implicated in nuclear
import, including NUP358/RANBP2, NUP153, and the importin-
b-family protein Transportin-SR2/TNPO3, were selective for HIV
(Figure 5A). TNPO3 was identified by Brass et al. (2008) as beingCell 135, 49–60, October 3, 2008 ª2008 Elsevier Inc. 53
important for HIV-1 infection, and here we demonstrate its
involvement in nuclear import of the PIC (Figure 5A). In contrast,
all genes that influence integration also affected infection by
MuLV (Figure 5A). Thus, the ability of the lentivirus HIV-1 to rep-
licate in nondividing cells (Lewis and Emerman, 1994), as com-
pared with MuLV, is reflected in the differences of host factors
needed for nuclear import (De Rijck et al., 2007). Interestingly,
the HIV PIC was unable to integrate into the host genome inde-
pendently of nuclear translocation in cycling cells (postnuclear
envelope breakdown), suggesting that HIV nuclear import
and integration may be functionally coupled processes (see
Discussion).
DISCUSSION
Here, we describe a genome-wide assay with an arrayed siRNA
library to identify genes required for early stages of HIV infection.
Inhibition of the gene function of putative host factors may
induce cellular responses that destabilize the viral cDNA, accel-
Figure 4. Host Factors Important for HIV-1 Reverse
Transcription
(A) 293T cells were transfected with siRNAs targeting indicated genes
and, after 48 hr, infected with pNL43R+E-luc(VSV-G). Real-time quantita-
tive PCR amplification analysis on DNA extracts was performed at the
indicated time points to assess for the amount of early and late viral RT
products. The left panel depicts a schematic of the reverse transcription
process and the corresponding primer/probe sets utilized for the quanti-
tative assay (red). Multiple experiments for one of more active siRNAs
targeting the same gene were considered to determine statistical signifi-
cance compared to negative controls (Wilcoxon signed-rank test) (right
panel). A pairwise comparison across the assays (data not shown) was
also performed, and then the factors were categorized into two functional
groups (indicated by the black bars). The black bars in the left panel
indicate the potential steps during reverse transcription in which the two
separate groups of factors are proposed to act. Additional factors that
influenced reverse transcription and could not be statistically segregated
into either of these two groups are indicated (unclassified).
(B) As in (A), reverse transcription was monitored with 293T cells that had
been transfected with siRNAs targeting indicated host mRNAs (lower
panel) or with a negative control siRNA GL2 (upper panel). For control
purposes, assays were also performed with the HIV-1 RT inhibitor AZT,
an HIV-1 integrase inhibitor, or with heat-inactivated virus. (Top panel)
Quantitative PCR values were normalized to an internal control gene,
and then to the control siRNAGL2 values. The right section of the heatmap
depicts the effects of gene inhibition on various cellular assays, including
infection by VSV-G or 10A1-pseudotyped HIV-1 vector, VSV-G-pseudo-
typed MuLV vector, or by AAV, as indicated, as well as on HIV-1 LTR-
mediated transcription (HIV integrated) and on cellular viability (TOX), as
described in Figure 1. Luciferase signal values were also normalized to
control siRNA GL2. Themedian relative activity is depicted in a continuum
of strong (blue) to weak (yellow). Only the genes that, upon depletion,
significantly alter the initiation or rate of reverse transcription are shown
(p < 0.001, Student’s t test).
erate turnover, or otherwise indirectly interfere with viral rep-
lication. To identify those proteins that are more likely to be
direct regulators of the viral life cycle, and thus be critical
for HIV-1 pathogenesis, we developed further selection crite-
ria, which took into consideration a number of additional, and
statistically significant, lines of evidence, including protein in-
teractions, mRNA expression, and gene ontology (Figure 1D;
Supplemental Data). Importantly, since this approach does not
only rely on identifying host factors based solely on ranking
siRNA activities, we were able to more effectively mine the
genetic data sets to identify those factorsmore likely to be imme-
diate regulators of HIV-1 infection, and establish a network of
host-pathogen interactions that coordinates HIV-1 infection. Ret-
rospective analysis showed that evidence scores of confirmed
genes are, on average, 40% higher than those that did not con-
firm (p = 9.7 3 1015), indicating that our approach enriched for
biologically relevant activities (Table S3; data not shown).
Further validation studies have identified over 40 host factors
that regulate capsid uncoating and reverse transcription steps of
early HIV-1 replication (Figure 4). Additionally, we have eluci-
dated 15 cellular factors that facilitate nuclear entry of the HIV-1
PIC and integration of proviral DNA (Figure 5). Importantly, only
genes that regulated infection with HIV-1 virus pseudotyped
with both VSV-G and 10A1 envelopes were considered for
further analysis, thus excluding factors that may regulate54 Cell 135, 49–60, October 3, 2008 ª2008 Elsevier Inc.
Figure 5. Host Factors Important for
Nuclear Import of HIV-1 PICs and Viral
DNA Integration
(A) 293T cells were transfectedwith siRNAs target-
ing indicated host factors or control siRNA (lower
panel) or were treated with an HIV-1 integrase
inhibitor and subsequently challenged with
pNL43R+Eluc(VSV-G). Real-time quantitative
PCR amplification analysis was then used to mea-
sure early and late RT products at 24 hr postinfec-
tion, as well as levels of 2-LTR circles and levels of
integrated viral DNA at 24 and 48 hr postinfection,
respectively. siRNA-transfected 293 T cells were
also subjected to the same infection, proviral ex-
pression, and toxicity screens as described in
Figure 4B (right panel of heatmap). The median
of at least three replicate experiments for one or
more active siRNAs targeting the same gene is
shown in a blue-to-yellow continuum. Genes
that, when inhibited, significantly impede viral
integration are shown (p < 0.01, Student’s t test).
Segregation of factors into nuclear import, likely
integration, and integration classes is primarily
based on the level of 2-LTR circles and is also sup-
ported by additional statistical significance calcu-
lations based upon the collective activity across all
PCR assays in comparison to positive (integrase
inhibitor) and negative (siGL2) controls (Figure S7).
(B) Representative single siRNA activities of nu-
clear envelope/import-associated genes in quan-
titative PCR assays reflect the dual categorization
of this class of proteins in both nuclear import (up-
per panel) and integration (middle panel). Relative
DNA copy numbers of early RT, late RT, 2-LTR cir-
cle formation, and integrated DNA as well statisti-
cal significance for 2-LTR circles and integrated
DNA are shown (p < 0.0001, Student’s t test). Error
bars represent standard deviations of the data.
(C) Biochemical relationships, based upon the
network analysis shown in Figure 3, between
proteins involved in integration (red) and nuclear
import (green) and direct or indirect interactions
among those proteins and with proteins encoded
by HIV (blue) are depicted.
(D) Amodel for themolecular coupling between nuclear import of the viral PIC and viral DNA integration processes. Proteins were organized as predicted from the
protein interaction data in (C) and are oriented on the basis of the quantitative PCR data (A and B).endosomal function associated with VSV-G-mediated entry (see
Figure 2C legend). Taken together, these studies indicate that
host cellular factors are involved in a variety of different cellular
processes that influence HIV-1 reverse transcription, nuclear im-
port, and integration.
Comparison with Reported HIV Host Factors Identified
through RNAi-Based Functional Screening
A recent genome-wide RNAi analysis by Brass et al. (2008)
has identified 284 genes as host cellular factors required for
HIV replication. Comparison with the 295 confirmed genes
presented here reveals a modest, but statistically significant,
overlap of 13 genes (p = 0.00021). We speculate that this mod-
erate concordance is largely due to differences in the analysis
and experimental methodologies used. For example, the criteria
Brass et al. (2008) employ to report host cellular factors are
genes targeted by one or more siRNAs with activities > 2 stan-dard deviations from the mean. Since 154 of the genes in the
Brass et al. study were supported by the activity of only a single
siRNA, it is likely that a fraction of these reported host factors
represent false-positive readouts due to off-target RNAi activity
(Echeverri et al., 2006).
If we apply the criteria used by Brass et al. to the data pre-
sented here, we can identify 60 genes that the two RNAi studies
have in common (p = 0.024; Table S8). Further reinforcing the
parallels, we find that, based upon protein network analysis, an
additional 64 genes reported by Brass et al. directly interact
with a confirmed gene in our study (p = 0.019; Table S8). In our
study, we have also prioritized gene activities not only based
upon siRNA activity, but also based on comparative activities
in additional screens, HIV-host protein interaction data, as well
as gene expression and ontology analysis. We anticipate that
this approach enabled us to enrich for the most relevant host
cellular factors that promote HIV infection, but this also likelyCell 135, 49–60, October 3, 2008 ª2008 Elsevier Inc. 55
contributed to the observed differences between the two host
factor data sets.
Several experimental differences must also be considered
when comparing these studies (also see Table S8). Two inde-
pendent RNAi libraries, constructed by using separate design
criteria and arrayed in different formats, were used to conduct
these screens. Also, we have employed a single-cycle, replica-
tion-defective HIV vector pseudotyped with a VSV-G envelope
in HEK293 cells andmeasured viral infection at a 24 hr time point.
Brass et al. (2008) monitored the replication of a wild-type X4
strain of HIV in CD4/CXCR4-expressing HeLa cells over the
course of 48 hr. Thus, we would not be able to identify factors in-
volved in CD4-mediated viral entry, as well as host molecules
that regulate late-stage HIV replication. In contrast, however,
we monitored single-cycle virus infectivity at an early (24 hr)
time point, which likely enabled us to elucidate a more compre-
hensive set of host factors specifically involved in the early
stages of replication, including uncoating, reverse transcription,
and integration. These also encompassed proteins that regulate
the kinetics of these processes (Figure 4A). Thus, whereas false-
positive activities are an inherent part of large-scale analyses, it
is likely that variations in both experimental and data analysis
techniques can largely account for the differences between our
results and those reported by Brass et al. (2008).
The Role of Cytoskeletal Proteins in Early HIV
Replication
The actin cytoskeleton was previously implicated in regulating
the initiation of HIV-1 reverse transcription (Bukrinskaya et al.,
1998) as well as in the movement of intracellular viral nucleopro-
tein complexes (NPCs) (Arhel et al., 2006). Consistently, the
present study has revealed important roles in the earliest steps
of HIV-1 infection for AKAP13, a RhoA-specific guanine nucleo-
tide exchange factor (GEF) that regulates actin stress fiber
formation; for NCKAP1, which associates with WAVE proteins
that regulate actin nucleation/organization; and for TAGLN-2,
a putative actin crosslinking/gelling protein (Table 1). Microtu-
bules, previously shown to be involved in the intracellular move-
ment of HIV-1 RTCs (Arhel et al., 2006; Naghavi et al., 2007), may
also play a regulatory role in reverse transcription, since viral
DNA levels were influenced by RP3-355C18.2, a predicted
tubulin tyrosine-ligase, and MID1IP1, involved in bundling and
stabilizing microtubules (Table 1). MID1IP1 was also identified
recently by Elledge and colleagues (Brass et al., 2008), but its
role in HIV-1 replication was not defined.
Involvement of the DNA-Damage Repair Pathway in HIV
Uncoating/Reverse Transcription
Cellular DNA repair machinery has been implicated in playing
roles in viral DNA integration and in the completion of viral DNA
synthesis after integration (Goff, 2007). An unanticipated finding
here was that proteins involved in DNA-damage response and
repair also influence the initiation of reverse transcription and
the accumulation of HIV-1 DNA products prior to integration
(Table 1). Moreover, we have found two locally dense networks
of proteins containing host factors that participate in DNA repair
(Figure 3C, DNA transcription/repair; Figure 3F, DNA damage/
replication). Both clusters contain multiple confirmed factors, in-56 Cell 135, 49–60, October 3, 2008 ª2008 Elsevier Inc.cluding POLR2A, XAB2, and ERCC5, which have been mapped
to early steps in the viral life cycle (Table 1). The viral interface for
this host-pathogen interaction is mediated by Vpr, a component
of the RTC/PIC that was recently being linked to the DNA-
damage response pathway (Schrofelbauer et al., 2007). Several
other DNA repair proteins, including MUS81, ERCC1, and
MRE11, involved in nucleotide excision repair were also
implicated in the early events of HIV-1 infection (Figure 2C).
Nucleic Acid-Binding Proteins Participate in the Early
Stages of HIV Replication
Retroviral reverse transcription presumably involves the un-
winding of RNA-RNA, RNA-DNA, and DNA-DNA strands, sug-
gesting, that one or more cellular helicase may participate in vi-
ral DNA synthesis. Our results indicate that DHX15, a putative
ATP-dependent RNA helicase that plays a role in pre-mRNA
splicing, is important for early viral DNA synthesis in target
cells (Table 1). Other nucleic acid-binding proteins, including
RBM17, were also implicated in regulating HIV-1 DNA synthesis
(Table 1). DHX15 and RBM17 are contained in a densely con-
nected network (Figure 3H), supporting their status as proximal
regulators of HIV-1 replication. In addition, several factors
involved in transcription or mRNA splicing that regulate viral un-
coating or reverse transcription were also identified (Table 1).
Correspondingly, two MCODE protein complexes, which
regulate transcription, splicing, and nucleic acid binding, were
identified through our network analysis (Figures 3D and 3E).
The latter cluster consists of 11 confirmed factors, of which 2
were required for reverse transcription, suggesting that these
proteins collectively coordinate either the uncoating or DNA
synthesis steps of HIV replication. It remains to be determined
whether these host proteins act by interacting directly with the
viral nucleic acids, or whether they regulate other host factors
required for HIV infection.
The Ubiquitin-Proteasome Pathway Is Required for
Capsid Uncoating and Viral DNA Synthesis
The ubiquitin-proteasome pathway has previously been associ-
ated with the early steps of HIV replication, where it acts
negatively to destroy incoming viral replication complexes
(Butler et al., 2002; Schwartz et al., 1998). Our studies have also
revealed a positive role for this pathway. The ubiquitin ligases
UBE2B (RAD6) and TRIAD3, as well as the proteasome compo-
nent PSMB2, were each important for HIV-1 reverse transcrip-
tion (Table 1). Network analysis also revealed that the viral
Integrase and Vif proteins have multiple interactions with a clus-
ter of proteins that function in the ubiquitin-proteasome pathway
(Figure 3B), indicating that these viral factors may play a struc-
tural role in the HIV RTC to recruit the proteosomal machinery
and facilitate uncoating or reverse transcription.
Posttranslational Modifications in Early HIV Replication
Previously, the cAMP-dependent protein kinase (PKA) was im-
plicated in regulating early steps of HIV-1 replication (Cartier
et al., 2003). AKAP13 is a PKA scaffold protein (Table 1) and
as such may be involved in mediating PKA-dependent regula-
tion of HIV-1 reverse transcription. Protein dephosphorylation
events may also act to regulate HIV-1 reverse transcription,
Table 1. Selected siRNA Phenotypes in Early Steps of HIV-1 Replication
Gene Names Functional Categorya Proposed Role in HIV Replication Replication Block
ERCC5, BTG2, NCOA6 DNA-damage repair DNA repair during RT RT initiation
DHX15 Nucleic acid binding Putative RNA helicase RT initiation
RBM17 Nucleic acid binding (RNA splicing) RNA binding RT initiation
AKAP13 Regulation of cytoskeleton PKA scaffold/actin organization RT initiation
NCKAP1 Regulation of cytoskeleton Actin organization RT initiation
SPEN Signal transduction Wnt-signaling regulation RT initiation
NUMBL Signal transduction Notch-signaling regulation RT initiation
POLR2A, SUB1, XAB2, RAD21 DNA-damage repair DNA repair during RT RT kinetics or viral DNA stability
R3HDM1 Nucleic acid binding Single-stranded RNA/DNA binding RT kinetics or viral DNA stability
RBM5, RBM10, RBM25 Nucleic acid binding (RNA splicing) RNA binding RT kinetics or viral DNA stability
SFRS6, PRPF8, SLU7 Nucleic acid binding (RNA splicing) RNA binding RT kinetics or viral DNA stability
RANBP17 Nuclear Import RNA binding RT kinetics or viral DNA stability
SUMO2 Posttranslational modification SUMOylation RT kinetics or viral DNA stability
RP3-355C18.2 Regulation of cytoskeleton Putative tubulin tyrosine ligase RT kinetics or viral DNA stability
TAGLN2 Regulation of cytoskeleton Actin organization RT kinetics or viral DNA stability
UBE2B Ubiquitin/proteasome Ubiquitin ligase RT kinetics or viral DNA stability
SNRPC Nucleic acid binding (RNA splicing) RNA binding RT (unclassified)
PPP1R14D Posttranslational modification Phosphatase activity RT (unclassified)
MID1IP1 Regulation of cytoskeleton Microtubule organization RT (unclassified)
PSEN2 Signal transduction Notch signaling RT (unclassified)
TRIAD3 Ubiquitin/proteasome Ubiquitin ligase RT (unclassified)
PSMB2 Ubiquitin/proteasome Proteasome component RT (unclassified)
TNPO3 Nuclear import Translocation of PIC Nuclear import
RANBP2 Nuclear import/posttranslation
modification
Translocation of PIC Nuclear import
NUP153 Nuclear pore component Translocation of PIC Nuclear import
NUP214 Nuclear pore component Translocation of PIC Nuclear import
PTGES3 Prostaglandin E synthesis Translocation of PIC Nuclear import
KPNB1 Nuclear import Integration coupling factors Integration
NUP98 Nuclear pore component Integration coupling factors Integration
ANAPC2 Anaphase promotion/ubiquitin
ligase activity
Putative tethering factors Integration
PRPF38A Nucleic acid binding Putative tethering factors Integration
SNW1 Transcriptional regulation Putative tethering factors Integration
AQR DNA repair Putative integration cofactor Integration
aReferences are contained in Table S9.as indicated by the importance of protein phosphatase 1 reg-
ulatory subunit 14D (PPP1R14D), a negative regulator of the
catalytic subunit of the serine/threonine protein phosphatase
1 (Table 1).
SUMOylation events have been proposed to be important in
the early steps of MuLV infection (Yueh et al., 2006). We have
found that SUMO-2, one of three small, ubiquitin-related
modifier proteins, is important during the late stage of HIV-1
(and MuLV) reverse transcription (Table 1). In addition, RANBP2,
a SUMO-1 E3 ligase that is a component of the cytoplasmic
filaments of the nuclear pore complex, was required for nuclear
import of the HIV-1 DNA (Table 1), perhaps through the
sumoylation of viral proteins in the PIC or host factors requiredin the PIC. Since RANBP2 influenced HIV, but not MuLV,
infection (Figure 4B), different SUMO conjugating systems may
be important for each of these two viruses.
Host Factors Required for Nuclear Import of the Viral
Preintegration Complex
The mechanism of HIV nuclear import is controversial, with mul-
tiple proteins and nucleic acids proposed to play a role (Suzuki
and Craigie, 2007). Our studies, combined with those of Brass
et al. (2008), indicate the involvement of NUP153, RANBP2,
and TNPO3 as factors involved in HIV-1 PIC import (Table 1).
We have also uncovered roles for NUP214; the nascent polypep-
tide-associated complex alpha subunit 2, NACA2; andCell 135, 49–60, October 3, 2008 ª2008 Elsevier Inc. 57
prostaglandin E synthase, PTGES3 (Table 1 and Figure 5). The
potential role of prostaglandins in HIV-1 nuclear import is partic-
ularly intriguing, because these factors are already known to reg-
ulate the import of other types of nuclear cargo (Gomez et al.,
2005; Malki et al., 2005), and they may represent a new thera-
peutic target for HIV-1 infection.
Host Proteins and Viral DNA Integration
Our studies have also revealed several cellular factors important
for HIV-1 DNA integration. The first is ANAPC2, a component of
the anaphase-promoting complex that promotes the meta-
phase-anaphase transition. ANAPC2 is a cullin protein with
a role in ubiquitin ligase activity (Table 1), suggesting that ubiqui-
tin modification and/or proteolysis of virus PIC components may
play a regulatory role during the integration stage of viral DNA
replication. Recent reports have suggested that passage
through mitosis may promote HIV as well as MLV DNA integra-
tion (Mannioui et al., 2004; Roe et al., 1993), providing a possible
role for ANAPC2. The second factor, SNW1, is a transcriptional
coactivator that associates with a cyclophilin-like protein, pep-
tidyl-prolyl isomerase-like 1 (PPIL1) (Table 1). The structure of
PPIL1 resembles that of other members of the cyclophilin family,
in particular Cyclophilin A (Xu et al., 2006), suggesting that cyclo-
philin proteins might be involved in regulating both late (integra-
tion) and early (uncoating) (Luban, 2007) replication steps. A third
factor, aquarius or AQR, also regulates HIV-1 DNA integration
(Figure 5A). This factor associates with XAB2, a protein involved
in transcription-coupled repair (Kuraoka et al., 2008), suggesting
that this DNA repair pathway might also play a role during viral
DNA integration.
A Model for Import-Coupled Integration
Protein networks that are implicated in nuclear import and inte-
gration of the HIV PIC are shown in Figure 5C. This network
was constructed based upon known or experimentally deter-
mined interactions between host factors and HIV-encoded
proteins, and proteins are organized and oriented on the basis
of the quantitative PCR mapping data (Figure 5A). Based upon
these data, we propose a model wherein nuclear import of the
PIC and proviral DNA integration are molecularly coupled events
mediated by nucleoporins, karyopherin, and putative tethering
factors (Figure 5D). Specifically, we hypothesize that nuclear
transport of the viral PIC through the nuclear pore complex is
mediated by soluble transport receptors, such as TNPO3, and
nuclear pore components (Stewart, 2007). Next, the PIC cargo
is transferred consecutively to phenylalanine-glycine (FG) repeat
domains of variant nucleoporins, for example NUP358/RANBP2.
Subsequently, in this model, the cargo is delivered to the FG
repeats of NUP214 (anchored to the cytoplasmic ring) and
NUP153 (distal ring). The FG repeats of both NUP214 and
NUP153 are highly flexible and can either reach down to the nu-
clear basket (NUP214) or toward the cytoplasmic periphery of
the central pore (NUP153) (Paulillo et al., 2005), thereby possibly
acting to accelerate PIC translocation. As an alternative, we can-
not rule out that RNAi silencing of nuclear import machinery
components may be acting indirectly by altering the localization
of protein(s) required for HIV nuclear import.58 Cell 135, 49–60, October 3, 2008 ª2008 Elsevier Inc.Upon traversing the nuclear pore, we hypothesize that the PIC
is then released into the nucleus through interaction with the
FG-containing NUP98 located near the nuclear basket, which
dynamically associates with and dissociates from the nuclear
pore (Griffis et al., 2004). Our data indicate that NUP98 is essen-
tial for viral integration, suggesting that NUP98 likely directs the
viral PIC from the nuclear pore to the proximity of the chromatin.
The intranuclear mobility of NUP98 has previously been linked to
active transcription sites, possibly through direct interactions
with the transcriptional machinery or with newly produced tran-
scripts and RNP complexes (Griffis et al., 2004). Additionally, the
PIC is anchored to chromatin through potential ‘‘tethering’’
factors. Targeted integration into active transcription units is
mediated by PSIP1/LEDGF/p75 (Ciuffi and Bushman, 2006)
(and references therein). Additional factors may help direct inte-
gration to transcriptionally active regions, as suggested by the
finding that histone posttranslational modifications associated
with expression positively correlate with HIV integration fre-
quency (Wang et al., 2007). We have identified several proteins
that are required for viral integration and are linked to
transcription, signaling, and splicing (ANAPC2, MT1X, SNW1,
IK, PRPF38A, and AQR). We hypothesize that these proteins
might act to target the PIC to the chromatin and/or act as
enzymatic cofactors for DNA integration. Our data indicate that
karyopherin KPNB1 is also required for viral integration, suggest-
ing that it may either cooperate with NUP98 to direct the PIC to
transcriptionally active chromatin or, alternatively, could serve as
an intermediate to couple the viral PIC to the tethering factors.
These data support a model in which components of nuclear im-
port machinery facilitate both HIV nuclear entry and integration,
and they suggest that the coupling of these steps is required for
the establishment of the HIV provirus.
Taken together, this integrative approach toward genome-
wide host-pathogen interaction analysis has revealed cellular
factors that coordinately regulate the early steps of HIV viral
replication, including those required for reverse transcription
and proviral establishment. To our knowledge, altogether new
pathways, such as the possible involvement of Notch signaling
in reverse transcription and prostaglandins in nuclear import,
are suggested for the first time. An understanding of their role
in cell types targeted by HIV during infection, such as helper
T cells, macrophages, and dendritic and microglial cells, will
be critical for characterizing the contribution of these factors to-
ward disease progression. The development of small molecules
that modulate the activity of these proteins may provide novel
strategies for the treatment of HIV/AIDS, particularly since the in-
hibition of early stages in the viral life cycle has already proven to
be therapeutically effective.
EXPERIMENTAL PROCEDURES
For detailed Experimental Procedures, see the Supplemental Data.
High-Throughput and Reconfirmation siRNA Screens
Genome-wide siRNA libraries targeting 19,628 human genes (2 siRNAs/well,
3 wells/gene) were screened in duplicate or triplicate runs by using a
high-throughput robotic system to identify siRNAs that influence the infection
of human 293T cells by either a VSV-G-pseudotyped HIV-1 reporter virus en-
coding luciferase, by a VSV-G-pseudotyped MLV vector encoding luciferase,
or by an AAV vector encoding luciferase. In addition, the library was
counterscreened to identify siRNAs that influence cell viability. siRNAs for
reconfirmation were individually rearrayed in 384 wells in duplicate and were
screened in at least 4 independent experiments and were analyzed as
described in the Supplemental Data.
Expression Vectors and Reporter Viruses
For the HIV andMLV screens, pNL43-Luc-ER+ (HIV-1 wild-typeDenv, encod-
ing firefly luciferase GL3) vector was used to generate VSV-G-pseudotyped
lentiviral supernatant, and the MLV-based retroviral vector pVGIP3, a deriva-
tive of pBabe, was used to generate a Moloney-based virus. For the AAV
screen, GL3 luciferase was introduced into an ITR-flanked AAV expression
vector to generate AAV particles encoding luciferase. For secondary confirma-
tion assays, an amphotropic 10A1 envelope-pseudotyped HIV virus was
generated.
Secondary Confirmation Analysis
Genes subject to staging of their effects in theHIV life cycle were also screened
in parallel for their activities on HIV-1 (VSV-G), HIV-1 (10A1), MLV (VSV-G), and
AAV reporter viruses as well on HIV-1 LTR-mediated transcription and cell
viability in 96-well-based assays.
Viral DNA Quantitation by Real-Time PCR
HEK293T cells were transfected with siRNAs and were infected with HIV-1
(VSV-G) 2 days later. Total DNA was isolated at 12 , 24, and 48 hr postinfection
(hpi). For control purposes, a reverse transcription inhibitor or integrase inhib-
itor was added at the time of infection. DNA was subject to real-time PCR to
specifically quantify HIV Early reverse transcription (RT) products, Late RT
products, 2-LTR circle forms, and Proviral DNA by using Alu-based nested
PCR. To normalize the amount of DNA in each PCR assay, the copy number
of the cellular gene porphobilinogen deaminase (PBGD) was quantified. With
each experiment, a standard curve was generated.
Yeast Two-Hybrid Screen with HIV Proteins
A yeast two-hybrid (Y2H) screen was performed by using the entire HIV HXB2
proteome as bait and screening against a human leukocyte cDNA library
cloned into the GAL4 expression vector.
Data Sets and Network Analysis
Multiple human protein-protein interaction databases, such as Y2H databases
and other curated literature-based protein-protein interaction databases
(Bind, HPRD, MINT, Reactome), were incorporated in the network analysis.
In addition, two human-HIV interaction databases (the NIAID HIV-1, Human
Protein Interaction Database and the Y2H in-house database) and the GNF
Tissue Atlas Gene Expression database were used in this study. Detailed
methodology of the multiscale strategy for hit selection and network analysis
can be found in Supplemental Data.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, eight
figures, and nineteen tables and are available with this article online at
http://www.cell.com/cgi/content/full/135/1/49/DC1/.
ACKNOWLEDGMENTS
Tracy L. Diamond is a Leukemia and Lymphoma Society Fellow (Grant #5217-
06). We thank U. O’Doherty and J.J. Yu for technical advice with the Alu-PCR
assay and Zhang J. for excellent technical assistance; Walter Tian and Eric
Lader (Qiagen GMBGH) for facilitating the acquisition of reagents used for
this study; and John Hogenesch for critical feedback on the manuscript.
This work was supported by a grant from the United States National Institutes
of Health (1 RO1 AI072645-01 to J.A.Y. and RO1 AI052845 to F.D.B.) and the
University of Pennsylvania Center for AIDS Research.Received: May 1, 2008
Revised: June 12, 2008
Accepted: July 18, 2008
Published: October 2, 2008
REFERENCES
Arhel, N., Genovesio, A., Kim, K.A., Miko, S., Perret, E., Olivo-Marin, J.C.,
Shorte, S., and Charneau, P. (2006). Quantitative four-dimensional tracking
of cytoplasmic and nuclear HIV-1 complexes. Nat. Methods 3, 817–824.
Bader, G.D., and Hogue, C.W. (2003). An automatedmethod for findingmolec-
ular complexes in large protein interaction networks. BMC Bioinformatics 4, 2.
Brass, A.L., Dykxhoorn, D.M., Benita, Y., Yan, N., Engelman, A., Xavier, R.J.,
Lieberman, J., and Elledge, S.J. (2008). Identification of host proteins required
for HIV infection through a functional genomic screen. Science 319, 817–824.
Bukrinskaya, A., Brichacek, B., Mann, A., and Stevenson, M. (1998). Establish-
ment of a functional human immunodeficiency virus type 1 (HIV-1) reverse
transcription complex involves the cytoskeleton. J. Exp. Med. 188, 2113–
2125.
Butler, S.L., Hansen, M.S., and Bushman, F.D. (2001). A quantitative assay for
HIV DNA integration in vivo. Nat. Med. 7, 631–634.
Butler, S.L., Johnson, E.P., and Bushman, F.D. (2002). Human immunodefi-
ciency virus cDNA metabolism: notable stability of two-long terminal repeat
circles. J. Virol. 76, 3739–3747.
Cartier, C., Hemonnot, B., Gay, B., Bardy, M., Sanchiz, C., Devaux, C., and
Briant, L. (2003). Active cAMP-dependent protein kinase incorporated within
highly purified HIV-1 particles is required for viral infectivity and interacts
with viral capsid protein. J. Biol. Chem. 278, 35211–35219.
Ciuffi, A., and Bushman, F.D. (2006). Retroviral DNA integration: HIV and the
role of LEDGF/p75. Trends Genet. 22, 388–395.
De Rijck, J., Vandekerckhove, L., Christ, F., and Debyser, Z. (2007). Lentiviral
nuclear import: a complex interplay between virus and host. Bioessays 29,
441–451.
Echeverri, C.J., Beachy, P.A., Baum, B., Boutros, M., Buchholz, F., Chanda,
S.K., Downward, J., Ellenberg, J., Fraser, A.G., Hacohen, N., et al. (2006).
Minimizing the risk of reporting false positives in large-scale RNAi screens.
Nat. Methods 3, 777–779.
Goff, S.P. (2007). Host factors exploited by retroviruses. Nat. Rev. Microbiol. 5,
253–263.
Gomez, P.F., Pillinger, M.H., Attur, M., Marjanovic, N., Dave, M., Park, J.,
Bingham, C.O., 3rd, Al-Mussawir, H., and Abramson, S.B. (2005). Resolution
of inflammation: prostaglandin E2 dissociates nuclear trafficking of individual
NF-kB subunits (p65, p50) in stimulated rheumatoid synovial fibroblasts. J.
Immunol. 175, 6924–6930.
Griffis, E.R., Craige, B., Dimaano, C., Ullman, K.S., and Powers, M.A. (2004).
Distinct functional domains within nucleoporins Nup153 and Nup98 mediate
transcription-dependent mobility. Mol. Biol. Cell 15, 1991–2002.
Hazuda, D.J., Felock, P., Witmer, M., Wolfe, A., Stillmock, K., Grobler, J.A.,
Espeseth, A., Gabryelski, L., Schleif, W., Blau, C., et al. (2000). Inhibitors of
strand transfer that prevent integration and inhibit HIV-1 replication in cells.
Science 287, 646–650.
Konig, R., Chiang, C.Y., Tu, B.P., Yan, S.F., DeJesus, P.D., Romero, A.,
Bergauer, T., Orth, A., Krueger, U., Zhou, Y., et al. (2007). A probability-based
approach for the analysis of large-scale RNAi screens. Nat. Methods 4, 847–
849.
Kuraoka, I., Ito, S., Wada, T., Hayashida, M., Lee, L., Saijo, M., Nakatsu, Y.,
Matsumoto, M., Matsunaga, T., Handa, H., et al. (2008). Isolation of XAB2
complex involved in pre-mRNA splicing, transcription, and transcription-
coupled repair. J. Biol. Chem. 283, 940–950.
Lewis, P.F., and Emerman, M. (1994). Passage through mitosis is required for
oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68,
510–516.Cell 135, 49–60, October 3, 2008 ª2008 Elsevier Inc. 59
Luban, J. (2007). Cyclophilin A, TRIM5, and resistance to human immunodefi-
ciency virus type 1 infection. J. Virol. 81, 1054–1061.
Malki, S., Nef, S., Notarnicola, C., Thevenet, L., Gasca, S., Mejean, C., Berta,
P., Poulat, F., and Boizet-Bonhoure, B. (2005). Prostaglandin D2 induces
nuclear import of the sex-determining factor SOX9 via its cAMP-PKA
phosphorylation. EMBO J. 24, 1798–1809.
Mannioui, A., Schiffer, C., Felix, N., Nelson, E., Brussel, A., Sonigo, P., Gluck-
man, J.C., and Canque, B. (2004). Cell cycle regulation of human immunode-
ficiency virus type 1 integration in T cells: antagonistic effects of nuclear
envelope breakdown and chromatin condensation. Virology 329, 77–88.
Mukherji, M., Bell, R., Supekova, L., Wang, Y., Orth, A.P., Batalov, S., Miraglia,
L., Huesken, D., Lange, J., Martin, C., et al. (2006). Genome-wide functional
analysis of human cell-cycle regulators. Proc. Natl. Acad. Sci. USA 103,
14819–14824.
Naghavi, M.H., Valente, S., Hatziioannou, T., de Los Santos, K., Wen, Y., Mott,
C., Gundersen, G.G., and Goff, S.P. (2007). Moesin regulates stable microtu-
bule formation and limits retroviral infection in cultured cells. EMBO J. 26,
41–52.
Nisole, S., and Saib, A. (2004). Early steps of retrovirus replicative cycle.
Retrovirology 1, 9.
Paulillo, S.M., Phillips, E.M., Koser, J., Sauder, U., Ullman, K.S., Powers, M.A.,
and Fahrenkrog, B. (2005). Nucleoporin domain topology is linked to the
transport status of the nuclear pore complex. J. Mol. Biol. 351, 784–798.
Roe, T., Reynolds, T.C., Yu, G., and Brown, P.O. (1993). Integration of murine
leukemia virus DNA depends on mitosis. EMBO J. 12, 2099–2108.
Schrofelbauer, B., Hakata, Y., and Landau, N.R. (2007). HIV-1 Vpr function is
mediated by interaction with the damage-specific DNA-binding protein
DDB1. Proc. Natl. Acad. Sci. USA 104, 4130–4135.60 Cell 135, 49–60, October 3, 2008 ª2008 Elsevier Inc.Schwartz, O., Marechal, V., Friguet, B., Arenzana-Seisdedos, F., and Heard,
J.M. (1998). Antiviral activity of the proteasome on incoming human immuno-
deficiency virus type 1. J. Virol. 72, 3845–3850.
Stewart, M. (2007). Molecular mechanism of the nuclear protein import cycle.
Nat. Rev. Mol. Cell Biol. 8, 195–208.
Suzuki, Y., and Craigie, R. (2007). The road to chromatin - nuclear entry of
retroviruses. Nat. Rev. Microbiol. 5, 187–196.
Wang, G.P., Ciuffi, A., Leipzig, J., Berry, C.C., and Bushman, F.D. (2007). HIV
integration site selection: analysis by massively parallel pyrosequencing re-
veals association with epigenetic modifications. Genome Res. 17, 1186–1194.
Xu, C., Zhang, J., Huang, X., Sun, J., Xu, Y., Tang, Y.,Wu, J., Shi, Y., Huang, Q.,
and Zhang, Q. (2006). Solution structure of human peptidyl prolyl isomerase-
like protein 1 and insights into its interaction with SKIP. J. Biol. Chem. 281,
15900–15908.
Yueh, A., Leung, J., Bhattacharyya, S., Perrone, L.A., de los Santos, K., Pu,
S.Y., and Goff, S.P. (2006). Interaction of moloney murine leukemia virus
capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in
infection. J. Virol. 80, 342–352.
Zar, J. (1999). Biostatistical Analysis, Fourth Edition (Upper Saddle River, NJ:
Prentice Hall).
Note Added in Proof
After acceptance of this manuscript, another study has also described a role
for TNPO3 in HIV-1 nuclear import (Christ et al., 2008, Curr. Biol. 18, 1192).
That study demonstrated a direct interaction between TNPO3 and HIV-1
Integrase.
